ARYA Sciences Acquisition Corp IV (ARYD): Price and Financial Metrics

ARYA Sciences Acquisition Corp IV (ARYD): $10.83

0.01 (+0.09%)

POWR Rating

Component Grades








ARYD Price/Volume Stats

Current price $10.83 52-week high $10.89
Prev. close $10.82 52-week low $9.91
Day low $10.83 Volume 100
Day high $10.83 Avg. volume 79,902
50-day MA $10.59 Dividend yield N/A
200-day MA $10.14 Market Cap 85.85M

ARYD Stock Price Chart Interactive Chart >

ARYA Sciences Acquisition Corp IV (ARYD) Company Bio

ARYA Sciences Acquisition Corp IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

ARYD Latest News Stream

Event/Time News Detail
Loading, please wait...

ARYD Latest Social Stream

Loading social stream, please wait...

View Full ARYD Social Stream

Latest ARYD News From Around the Web

Below are the latest news stories about ARYA SCIENCES ACQUISITION CORP IV that investors may wish to consider to help them evaluate ARYD as an investment opportunity.

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors announced today that, due to existing market conditions, it has mutually agreed with Amicus Therapeutics, Inc. (Nasdaq: FOLD) (“Amicus”) to terminate their previously announced Business Combination Agreement (the “Business Combination Agreement”), effective immediately. “While this is not the outcome we ha

Yahoo | February 24, 2022

Read More 'ARYD' Stories Here

ARYD Price Returns

1-mo 0.65%
3-mo N/A
6-mo 4.84%
1-year 9.17%
3-year N/A
5-year N/A
YTD 7.23%
2022 1.87%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!